Trial NCT03414450

View at ClinicalTrials.gov 
Org. Study IDs: D3-005

Last trial update was posted on 2018-10-25

MeSH Interventions

Dasatinib

MeSH Conditions

Blast Crisis Leukemia Leukemia, Lymphoid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) Ph- Acute Lymphoblastic Leukemia (Ph-ALL)

Stopping Reasons

Withdrawal requested by D3

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID